← Leaderboards
Vivek Mittal
Weill Medical Coll Of Cornell Univ
$10,850,597
Attributed
$22,925,175
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,580,501 · 14
By mechanism
R01$14,173,865 · 7
U54$4,900,343 · 3
UH3$2,932,940 · 1
U01$2,519,316 · 1
UG3$2,054,037 · 1
RC1$1,000,000 · 1
Top collaborators
- Nasser Khaled Altorki16 shared
- Timothy E Mcgraw13 shared
- Alain C Borczuk9 shared
- Olivier Elemento9 shared
- Linda Theresa Vahdat6 shared
- Robert I Benezra5 shared
- Randolph S Watnick5 shared
- Stephen Tc Wong5 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Nasser Khaled Altorki$2,970,612
- Steven Monroe Lipkin$27,661,021
- Alain C Borczuk$997,395
- Olivier Elemento$10,592,678
- Linda Theresa Vahdat$1,571,187
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelTumorCellsNeoplastic CellLungMalignant NeoplasmsPhenotypeCancer CellBasePre-ClinicalMolecularPathway InteractionsInsightMediatingNeoplasm MetastasisClinical TrialsMalignant Neoplasm Of LungTumor MicroenvironmentPreventNon-Small-Cell Lung CarcinomaProteinsResponseSamplingEndothelial Cells
Grant awards (50)
CAP-IT Center for LNP RNA Immunoprevention$1,315,413
U54 · FY2025 · CA · contact PI
Immunoregulatory role of lung-resident club cell factors in lung cancer$679,154
R01 · FY2025 · CA · contact PI
ER stress-driven IRE1a-XBP1 signaling in lung cancer$663,481
R01 · FY2025 · CA · contact PI
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis$546,681
R01 · FY2025 · CA · contact PI
Therapeutic targeting of the tumor microenvironment in triple negative breast cancer patients at high risk of relapse and preclinical models of lung metastases$442,343
R01 · FY2025 · CA
The Computational Tumor Immunology Core (CTIC)$140,909
U54 · FY2025 · CA · contact PI
CAP-IT CRI U54 ADMINISTRATIVE CORE$104,108
U54 · FY2025 · CA · contact PI
CAP-IT Center for LNP RNA Immunoprevention$1,060,438
U54 · FY2024 · CA
Immunoregulatory role of lung-resident club cell factors in lung cancer$645,197
R01 · FY2024 · CA · contact PI
ER stress-driven IRE1a-XBP1 signaling in lung cancer$630,307
R01 · FY2024 · CA · contact PI
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis$519,193
R01 · FY2024 · CA · contact PI
CAP-IT Center for LNP RNA Immunoprevention$1,098,880
U54 · FY2023 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$805,881
UH3 · FY2023 · CA
Immunoregulatory role of lung-resident club cell factors in lung cancer$679,154
R01 · FY2023 · CA · contact PI
ER stress-driven IRE1a-XBP1 signaling in lung cancer$663,481
R01 · FY2023 · CA · contact PI
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis$535,436
R01 · FY2023 · CA · contact PI
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$234,178
UH3 · FY2023 · CA
CAP-IT Center for LNP RNA Immunoprevention$1,180,595
U54 · FY2022 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$808,655
UH3 · FY2022 · CA
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis$535,285
R01 · FY2022 · CA · contact PI
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$238,958
UH3 · FY2022 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$845,268
UH3 · FY2021 · CA
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis$563,435
R01 · FY2021 · CA · contact PI
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$249,999
UG3 · FY2021 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$836,730
UG3 · FY2020 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$130,578
UG3 · FY2020 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$836,730
UG3 · FY2019 · CA
Modeling tumor-stroma crosstalk in lung cancer to identify targets for therapy$513,981
U01 · FY2019 · CA
Modeling tumor-stroma crosstalk in lung cancer to identify targets for therapy$431,112
U01 · FY2018 · CA
Modeling tumor-stroma crosstalk in lung cancer to identify targets for therapy$411,967
U01 · FY2017 · CA
Modeling tumor-stroma crosstalk in lung cancer to identify targets for therapy$567,645
U01 · FY2016 · CA
The role of endothelial progenitor cells in tumor growth and metastasis$606,260
R01 · FY2015 · CA
Modeling tumor-stroma crosstalk in lung cancer to identify targets for therapy$594,611
U01 · FY2015 · CA
The role of endothelial progenitor cells in tumor growth and metastasis$590,291
R01 · FY2014 · CA
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str$510,814
R01 · FY2014 · CA · contact PI
The role of endothelial progenitor cells in tumor growth and metastasis$574,230
R01 · FY2013 · CA
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str$492,966
R01 · FY2013 · CA · contact PI
The role of endothelial progenitor cells in tumor growth and metastasis$613,264
R01 · FY2012 · CA
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str$526,470
R01 · FY2012 · CA · contact PI
The role of endothelial progenitor cells in tumor growth and metastasis$608,475
R01 · FY2011 · CA
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str$495,460
R01 · FY2011 · CA · contact PI
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str$529,299
R01 · FY2010 · CA · contact PI
Microfluidic tumor models to analyze the role of physicochemical cues in the angi$500,000
RC1 · FY2010 · CA
Microfluidic tumor models to analyze the role of physicochemical cues in the angi$500,000
RC1 · FY2009 · CA
ANALYSIS OF Id GENE TARGETS IN TUMOR ENDOTHELIAL CELLS$169,809
R01 · FY2008 · CA · contact PI
ANALYSIS OF Id GENE TARGETS IN TUMOR ENDOTHELIAL CELLS$126,714
R01 · FY2008 · CA · contact PI
ANALYSIS OF Id GENE TARGETS IN TUMOR ENDOTHELIAL CELLS$296,523
R01 · FY2007 · CA · contact PI
ANALYSIS OF Id GENE TARGETS IN TUMOR ENDOTHELIAL CELLS$305,379
R01 · FY2006 · CA · contact PI
ANALYSIS OF Id GENE TARGETS IN TUMOR ENDOTHELIAL CELLS$312,728
R01 · FY2005 · CA
ANALYSIS OF Id GENE TARGETS IN TUMOR ENDOTHELIAL CELLS$312,036
R01 · FY2004 · CA